BLU-667 100 mg (Gavreto 100 mg)
Generic Name: pralsetinib
Pill with imprint BLU-667 100 mg is Blue, Capsule-shape and has been identified as Gavreto 100 mg. It is supplied by Genentech, Inc..
Gavreto is used in the treatment of non-small cell lung cancer; thyroid cancer and belongs to the drug class multikinase inhibitors. Gavreto 100 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for BLU-667 100 mg
More about Gavreto (pralsetinib)
- Side Effects
- During Pregnancy
- Dosage Information
- Drug Images
- Drug Interactions
- Pricing & Coupons
- En Español
- Drug class: multikinase inhibitors
- FDA Approval History
Related treatment guides
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.